Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lerman

Showing results (151-160 of 4,478) with videos related to

Pageof 448
Sort By:
JACC. Cardiovascular Interventions|October 20, 2018
Coronary Microvasculature: Are the Small and the Mighty Cross-Talking With the Epicardial Vessels?Michel T Corban, Lilach O Lerman, Amir Lerman
Journal of the American Geriatrics Society|May 20, 2015
Response to Lavan and colleaguesDvora Frankenthal, Yehuda Lerman, Yaffa Lerman, et al.
Biomarkers in Medicine|June 17, 2010
Endothelial function as a functional expression of cardiovascular risk factorsMartin K Reriani, Lilach O Lerman, Amir Lerman
European Heart Journal|February 8, 2020
Endothelin-1 in coronary microvascular dysfunction: a potential new therapeutic target once againMichel T Corban, Lilach O Lerman, Amir Lerman
Journal of Laboratory and Precision Medicine|August 28, 2018
Cardiorenal biomarkers: one step closerXiao-Jun Chen, Amir Lerman, Lilach O Lerman
Circulation. Cardiovascular Interventions|October 18, 2012
Low-flow motion in the vascular oceanR Jay Widmer, Lilach O Lerman, Amir Lerman
Cardiovascular Research|January 21, 2004
The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extendedJoerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Mayo Clinic Proceedings|December 5, 2021
Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19Megha Prasad, Martin Leon, Lilach O Lerman, et al.
International Journal of Cardiovascular Interventions|July 16, 2005
The ubiquitin-proteasome system--micro target for macro intervention?Joerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Cardiovascular Research|April 25, 2013
Osteopontin: an emerging therapeutic target in uraemic vascular diseaseXin Zhang, Alfonso Eirin, Amir Lerman, et al.
Pageof 448

Showing results (151-160 of 4,478) with videos related to

Sort By:
Pageof 448
JACC. Cardiovascular Interventions|October 20, 2018
Coronary Microvasculature: Are the Small and the Mighty Cross-Talking With the Epicardial Vessels?Michel T Corban, Lilach O Lerman, Amir Lerman
Journal of the American Geriatrics Society|May 20, 2015
Response to Lavan and colleaguesDvora Frankenthal, Yehuda Lerman, Yaffa Lerman, et al.
Biomarkers in Medicine|June 17, 2010
Endothelial function as a functional expression of cardiovascular risk factorsMartin K Reriani, Lilach O Lerman, Amir Lerman
European Heart Journal|February 8, 2020
Endothelin-1 in coronary microvascular dysfunction: a potential new therapeutic target once againMichel T Corban, Lilach O Lerman, Amir Lerman
Journal of Laboratory and Precision Medicine|August 28, 2018
Cardiorenal biomarkers: one step closerXiao-Jun Chen, Amir Lerman, Lilach O Lerman
Circulation. Cardiovascular Interventions|October 18, 2012
Low-flow motion in the vascular oceanR Jay Widmer, Lilach O Lerman, Amir Lerman
Cardiovascular Research|January 21, 2004
The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extendedJoerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Mayo Clinic Proceedings|December 5, 2021
Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19Megha Prasad, Martin Leon, Lilach O Lerman, et al.
International Journal of Cardiovascular Interventions|July 16, 2005
The ubiquitin-proteasome system--micro target for macro intervention?Joerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Cardiovascular Research|April 25, 2013
Osteopontin: an emerging therapeutic target in uraemic vascular diseaseXin Zhang, Alfonso Eirin, Amir Lerman, et al.
Pageof 448